About: Inflammation and bone erosion are suppressed in models of rheumatoid arthritis following treatment with a novel Syk inhibitor

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Inflammation and bone erosion are suppressed in models of rheumatoid arthritis following treatment with a novel Syk inhibitor Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 29 May 2007

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в травні 2007 (uk) article scientifique publié en 2007 (fr) im Mai 2007 veröffentlichter wissenschaftlicher Artikel (de) scientific article published on 29 May 2007 (en) artículu científicu espublizáu en mayu de 2007 (ast)
publication date	wds:Q80405031-13073C86-2D2B-459A-BE21-B486DE3353AE
publication date	2007-05-29 00:00:00Z (xsd:dateTime)
author name string	wds:Q80405031-12152EC3-4C34-4E4D-A8BB-3F8D933B8171 wds:Q80405031-1228DAA1-67E3-411E-AF93-46E30BACD965 wds:Q80405031-2D012031-43E9-4B64-98ED-F3A8734CFF2A wds:Q80405031-62191EE2-5E11-401D-B0E7-3B5B38B3AEE5 wds:Q80405031-9F3ED9DE-C44E-477F-A62D-8473BAEBD6DB wds:Q80405031-A3E046F4-18DE-42B4-9633-F675388577A8 wds:Q80405031-C789366B-3134-47E6-B38E-B47827EF4030 wds:Q80405031-DCAD62C2-7331-4D71-9088-D411017CE823 wds:Q80405031-E80C36EE-02EE-4EA3-8FCD-10A81F342391 wds:Q80405031-F626AC1D-61C8-49DB-B0D8-E091293B6737
author name string	Su Wang Donald G Payan Angela Lau Elliott B Grossbard Nathan Schoettler Feifei Zhao Betty Chang Ernest Brahn Mona L Banquerigo Polly R Pine
rdfs:label	Inflammation and bone erosion are suppressed in models of rheumatoid arthritis following treatment with a novel Syk inhibitor (en) Inflammation and bone erosion are suppressed in models of rheumatoid arthritis following treatment with a novel Syk inhibitor (nl)
skos:prefLabel	Inflammation and bone erosion are suppressed in models of rheumatoid arthritis following treatment with a novel Syk inhibitor (en) Inflammation and bone erosion are suppressed in models of rheumatoid arthritis following treatment with a novel Syk inhibitor (nl)
name	Inflammation and bone erosion are suppressed in models of rheumatoid arthritis following treatment with a novel Syk inhibitor (en) Inflammation and bone erosion are suppressed in models of rheumatoid arthritis following treatment with a novel Syk inhibitor (nl)
title	wds:Q80405031-58FA5024-C972-474E-86CA-57A3916B6C16
title	Inflammation and bone erosion are suppressed in models of rheumatoid arthritis following treatment with a novel Syk inhibitor (en)
page(s)	wds:Q80405031-8496CBD2-BE1B-4C99-8E8D-CEDF411DD1DA
page(s)	244-257
instance of	wds:Q80405031-C13AB68D-FBE4-4736-84FC-1A2DA97316F9
instance of	scholarly article
main subject	wds:Q80405031-72D202E6-7D30-4297-8E5B-25326DEB8303
main subject	rheumatoid arthritis
PubMed ID	wds:Q80405031-7718086E-0277-4CED-B2BC-AB90CEF5427B
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/17537677
PubMed ID	17537677
published in	wds:Q80405031-D10EB902-A6B0-42A4-BDDB-A4B5E8101551
published in	Clinical Immunology
issue	wds:Q80405031-4353B9D9-D671-4BAC-A4D7-5873065D3DA6
volume	wds:Q80405031-D7FE750D-38AB-44EF-B479-25D413D00EB9
issue	3
volume	124
DOI	wds:Q80405031-61154ACE-240C-4CC8-B5DF-9E3163D4AD8D
DOI	http://dx.doi.org/10.1016/J.CLIM.2007.03.543
DOI	10.1016/J.CLIM.2007.03.543
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q80405031
is cites work of	The Bruton tyrosine kinase inhibitor PCI-32765 ameliorates autoimmune arthritis by inhibition of multiple effector cells Syk kinase signalling couples to the Nlrp3 inflammasome for anti-fungal host defence The SYK tyrosine kinase: a crucial player in diverse biological functions Innate immunity and rheumatoid arthritis Garden of therapeutic delights: new targets in rheumatic diseases Platelets mediate lymphovenous hemostasis to maintain blood-lymphatic separation throughout life. Getting Syk: spleen tyrosine kinase as a therapeutic target. Overexpression of Syk tyrosine kinase in peripheral T-cell lymphomas. Spleen tyrosine kinase inhibitors for rheumatoid arthritis: where are we now? Genetic deficiency of Syk protects mice from autoantibody-induced arthritis. Spleen tyrosine kinase inhibition in the treatment of autoimmune, allergic and autoinflammatory diseases Functional roles of Syk in macrophage-mediated inflammatory responses Advances in rheumatology: new targeted therapeutics "Go upstream, young man": lessons learned from the p38 saga Mechanisms of immune complex-mediated neutrophil recruitment and tissue injury. Suppression of autoimmune arthritis by Celastrus-derived Celastrol through modulation of pro-inflammatory chemokines Kinase inhibitors: a new class of antirheumatic drugs Role of spleen tyrosine kinase inhibitors in the management of rheumatoid arthritis Back to the future: oral targeted therapy for RA and other autoimmune diseases The arthritis severity locus Cia5a regulates the expression of inflammatory mediators including Syk pathway genes and proteases in pristane-induced arthritis. A multitude of kinases--which are the best targets in treating rheumatoid arthritis? Novel molecular targets in the treatment of systemic lupus erythematosus Therapeutic targeting of Syk in autoimmune diabetes Targeting innate immunity protein kinase signalling in inflammation Pharmacokinetics of fostamatinib, a spleen tyrosine kinase (SYK) inhibitor, in healthy human subjects following single and multiple oral dosing in three phase I studies Suppression of skin and kidney disease by inhibition of spleen tyrosine kinase in lupus-prone mice Is there a role of synovial biopsy in drug development? Protein kinase inhibitors in the treatment of inflammatory and autoimmune diseases Progress in treatment of ANCA-associated vasculitis Targeting Syk in Autoimmune Rheumatic Diseases Neutrophils: game changers in glomerulonephritis? Cellular targeting in autoimmunity Cell-signaling therapy in rheumatoid arthritis Cytokines: Names and Numbers You Should Care About A decade of the human genome sequence--how does the medicinal chemist benefit? Comparison of the anti-allergic activity of Syk inhibitors with optimized Syk siRNAs in FcepsilonRI-activated RBL-2H3 basophilic cells Transglutaminase 2 cross-linking activity is linked to invadopodia formation and cartilage breakdown in arthritis Imidazotriazines: Spleen Tyrosine Kinase (Syk) Inhibitors Identified by Free-Energy Perturbation (FEP) A spleen tyrosine kinase inhibitor reduces the severity of established glomerulonephritis Tyrosine kinases in rheumatoid arthritis Aberrant SYK Kinase Signaling Is Essential for Tumorigenesis Induced by TSC2 Inactivation. Advances in rheumatoid arthritis animal models Alveolar Bone Protection by Targeting the SH3BP2-SYK Axis in Osteoclasts wd:Q95359658

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software